The New York Times
CHICAGO (Reuters) — Women who took hormone replacement therapy after menopause had a sharply increased risk of ovarian cancer, researchers in Denmark are reporting.
In a study of more than 900,000 Danish women ages 50 to 79, the scientists found 140 extra cases of ovarian cancer linked to hormone treatment over eight years. That translated to a 38 percent greater risk of contracting the disease, compared with women who did not receive the therapy... Read More
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Penn Cancer Network
